Jenburkt Pharmaceuticals informs about unaudited financial results

30 Jul 2019 Evaluate

Jenburkt Pharmaceuticals has informed that the Board of Directors of the Company has approved the unaudited financial results for the quarter ended 30th June, 2019.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1025.50 -35.80 (-3.37%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×